Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
burger-menu close-panel
🤝 We're Hiring! Apply now to join the Lozier Institute team
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Peer Reviewed

Peer Reviewed

Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
37 results

Filter Results By

Filter Applied. Clear All

Latest Posts

December 20, 2024 Strengthening the Pro-Life Safety Net: Federal Transportation Policy Strengthening the Pro-Life Safety Net: Federal Transportation Policy December 19, 2024 End of Year Update: Tax Credits for Life Affirming Organizations End of Year Update: Tax Credits for Life Affirming Organizations December 19, 2024 Fact Sheet: Abortions at or after 15 Weeks in the United States Fact Sheet: Abortions at or after 15 Weeks in the United States
Research Type
Publication Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

37 results
featured-image
Peer Reviewed

A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015

Existing research on postabortion emergency room visits is sparse and limited by methods which underestimate the incidence of adverse events following abortion. Postabortion emergency room (ER) use since Food and Drug Administration approval of chemical abortion in 2000 can identify trends in the relative morbidity burden of chemical versus surgical procedures.

James Studnicki, Sc.D., MPH, MBA Donna Harrison, M.D.
November 9, 2021
Please login to bookmark Close
featured-image
Peer Reviewed

Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019

Objectives: Primary: Analyze the Adverse Events (AEs) reported to the Food and Drug Administration (FDA) after use of mifepristone as an abortifacient. Secondary: Analyze maternal intent after ongoing pregnancy and investigate hemorrhage after mifepristone alone.

Kathi Aultman, M.D. Christina A. Cirucci, M.D.
November 1, 2021
Please login to bookmark Close
featured-image
Peer Reviewed

Estimating the Period Prevalence of Mothers Who Have Abortions: A Population Based Study of Inclusive Pregnancy Outcomes

The prevalence of induced abortion among women with children has been estimated indirectly by projections derived from survey research. However, an empirically derived, population-based conclusion on this question is absent from the published literature.

James Studnicki, Sc.D., MPH, MBA John W. Fisher, Ph.D., J.D., M.S., M.A.
July 23, 2021
Please login to bookmark Close
featured-image
Peer Reviewed

Intervals and Outcomes of First and Second Pregnancies in Low-Income Women: A Record-Linkage Longitudinal Prospective Cohort Study

The number of pregnancies and interval between pregnancies can have significant impact on a woman’s reproductive, psychological, and general health. Exposure to multiple reproductive losses is especially associated with higher rates of negative outcomes.

David C. Reardon, Ph.D.
June 15, 2021
Please login to bookmark Close
featured-image
Peer Reviewed

Estimating the Period Prevalence of Publicly Funded Abortion to Space Live Births, 1999 to 2014

Although a majority of women who have an abortion report having 1 or more children, there is no published research on the number of abortions which occur between live births, after a first child but before the last. The objectives of this research, therefore, were to estimate the period prevalence of an induced abortion separating live births in a population of Medicaid eligible enrollees and to identify the characteristics of enrollees significantly associated with the use of abortion to enable child spacing.

James Studnicki, Sc.D., MPH, MBA John W. Fisher, Ph.D., J.D., M.S., M.A.
May 6, 2021
Please login to bookmark Close
featured-image
Peer Reviewed

Effects of Pregnancy Loss on Subsequent Postpartum Mental Health: A Prospective Longitudinal Cohort Study

Pregnancy loss, natural or induced, is linked to higher rates of mental health problems, but little is known about its effects during the postpartum period. This study identifies the percentages of women receiving at least one postpartum psychiatric treatment (PPT), defined as any psychiatric treatment (ICD-9 290-316) within six months of their first live birth, relative to their history of pregnancy loss, history of prior mental health treatments, age, and race.

David C. Reardon, Ph.D.
February 23, 2021
Please login to bookmark Close
featured-image
Peer Reviewed

Perceiving and Addressing the Pervasive Racial Disparity in Abortion

Black women have been experiencing induced abortions at a rate nearly 4 times that of White women for at least 3 decades, and likely much longer. The impact in years of potential life lost, given abortion’s high incidence and racially skewed distribution, indicates that it is the most demographically consequential occurrence for the minority population.

James Studnicki, Sc.D., MPH, MBA James L. Sherley, M.D., Ph.D.
August 18, 2020
Please login to bookmark Close
featured-image
Peer Reviewed

Pregnancy Outcome Patterns of Medicaid-Eligible Women, 1999-2014: A National Prospective Longitudinal Study

The objective of this study was to describe the characteristic patterns of subsequent pregnancy outcomes evolving from each of three initiating outcome events (birth, induced abortion, natural fetal loss) occurring in a Medicaid population fully insured for all reproductive health services.

James Studnicki, Sc.D., MPH, MBA John W. Fisher, Ph.D., J.D., M.S., M.A.
July 31, 2020
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image